Combined quantitative analysis holds promise for tumour proteins
Sep 21 2010
Scientists from Sweden's Karolinska Institute and AstraZeneca's research and development facility in Sodertalje carried out multivariate testing on proteomics data obtained from tumours in the human colon and prostate.
They used existing data from two-dimensional gel electrophoresis to undertake quantitative analysis of proteins from different tumours in order to uncover any common patterns between them.
While previous research focusing on a single tumour type had not uncovered patterns in some proteins, the multivariate partial least squares approach adopted by the scientists was able to overcome this.
As a result, 14 proteins were identified for the two tumour types - colon and prostate - with matching patterns of differential expression in normal and malignant tissue.
BMC Bioinformatics carries peer-reviewed journal articles on novel statistical and computational approaches to analysing biological data.
In This Edition Modern & Practocal Applications - Accelerating ADC Development with Mass Spectrometry - Implementing High-Resolution Ion Mobility into Peptide Mapping Workflows Chromatogr...
View all digital editions
Oct 10 2023 Hybrid event
Oct 15 2023 Katowice, Poland
Nov 05 2023 Vienna, Austria
Nov 12 2023 Louisville, KY, USA
Nov 13 2023 Plainsboro, NJ, USA